The Correlation of Centromere Protein Q with Diagnosis and Prognosis in Hepatocellular Carcinoma

References

• Affo S, Yu LX, Schwabe RF. The role of cancer-associated fibroblasts and fibrosis in liver cancer. Ann Revi Pathol. 2017;12(153–186):153–186. doi:10.1146/annurev-pathol-052016-100322
   PubMedGoogle Scholar
• Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv238–iv255. doi:10.1093/annonc/mdy308
   PubMed Web of Science ®Google Scholar
• Thomas MB, Jaffe D, Choti MM, et al. Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting. J Clin Oncol. 2010;28(25):3994–4005. doi:10.1200/JCO.2010.28.7805
   PubMed Web of Science ®Google Scholar
• Sangro B, Gomez-Martin C, De La Mata M, et al. A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C. J Hepatol. 2013;59(1):81–88. doi:10.1016/j.jhep.2013.02.022
   PubMed Web of Science ®Google Scholar
• El-Khoueiry AB, Sangro B, Yau T, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, Phase 1/2 dose escalation and expansion trial. Lancet. 2017;389(10088):2492–2502. doi:10.1016/S0140-6736(17)31046-2
   PubMed Web of Science ®Google Scholar
• Zhu AX, Finn RS, Edeline J, et al. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label Phase 2 trial. Lancet Oncol. 2018;19(7):940–952. doi:10.1016/S1470-2045(18)30351-6
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118–1127. doi:10.1056/NEJMra1001683
   PubMed Web of Science ®Google Scholar
• Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557–588. doi:10.1038/s41575-020-0310-z
   PubMed Web of Science ®Google Scholar
• Johnson SC, Mcclelland SE. Watching cancer cells evolve through chromosomal instability. Nature. 2019;570(7760):166–167. doi:10.1038/d41586-019-01709-2
   PubMedGoogle Scholar
• Liu Y, Xiong S, Liu S, et al. Analysis of gene expression in bladder cancer: possible involvement of mitosis and complement and coagulation cascades signaling pathway. J Comput Biol. 2020;27(6):987–998. doi:10.1089/cmb.2019.0237
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen C, Yan M, et al. CENPO regulated proliferation and apoptosis of colorectal cancer in a p53-dependent manner. Discover Oncol. 2022;13(1):8. doi:10.1007/s12672-022-00469-2
   PubMedGoogle Scholar
• Y CAO, XIONG J, LI Z, et al. CENPO expression regulates gastric cancer cell proliferation and is associated with poor patient prognosis. Molecu Med Rep. 2019;20(4):3661–3670. doi:10.3892/mmr.2019.10624
   PubMed Web of Science ®Google Scholar
• He P, Hu P, Yang C, et al. Reduced expression of CENP-E contributes to the development of hepatocellular carcinoma and is associated with adverse clinical features. Biomed Pharmacother. 2020;123:109795. doi:10.1016/j.biopha.2019.109795
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen X, Wang L, et al. Centromere Protein F (CENPF) serves as a potential prognostic biomarker and target for human hepatocellular carcinoma. J Cancer. 2021;12(10):2933–2951. doi:10.7150/jca.52187
   PubMed Web of Science ®Google Scholar
• Lu G, Hou H, Lu X, et al. CENP-H regulates the cell growth of human hepatocellular carcinoma cells through the mitochondrial apoptotic pathway. Oncol Rep. 2017;37(6):3484–3492. doi:10.3892/or.2017.5602
   PubMed Web of Science ®Google Scholar
• He K, Xie M, Li J, et al. CENPO is associated with immune cell infiltration and is a potential diagnostic and prognostic marker for hepatocellular carcinoma. Int J Gen Med. 2022;15:7493–7510. doi:10.2147/IJGM.S382234
   PubMed Web of Science ®Google Scholar
• Zhou Y, Chai H, Guo L, et al. Knockdown of CENPW inhibits hepatocellular carcinoma progression by inactivating E2F signaling. Technol Cancer Res Treat. 2021;20:15330338211007253. doi:10.1177/15330338211007253
   Google Scholar
• Qian W, Yang L, Ni Y, et al. LncRNA LINC01857 reduces metastasis and angiogenesis in breast cancer cells via regulating miR-2052/CENPQ axis. Open Med. 2022;17(1):1357–1367. doi:10.1515/med-2022-0525
   Web of Science ®Google Scholar
• Diaz G, Engle RE, Tice A, et al. Molecular signature and mechanisms of hepatitis D virus-associated hepatocellular carcinoma. Mol Cancer Res. 2018;16(9):1406–1419. doi:10.1158/1541-7786.MCR-18-0012
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallström BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. doi:10.1126/science.1260419
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;14(1):7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2021;71(3):209–249. doi:10.3322/caac.21660
   Web of Science ®Google Scholar
• Perpelescu M, Fukagawa T. The ABCs of CENPs. Chromosoma. 2011;120(5):425–446. doi:10.1007/s00412-011-0330-0
   PubMed Web of Science ®Google Scholar
• Qi CL, Huang ML, Zou Y, et al. The IRF2/CENP-N/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis. J Exp Clin Cancer Res. 2021;40(1):390. doi:10.1186/s13046-021-02191-3
   PubMed Web of Science ®Google Scholar
• Wang J, Li H, Xia C, et al. Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1. Onco Targets Ther. 2019;12(869–882):1.
   PubMedGoogle Scholar
• Takahashi Y, Tanikawa C, Miyamoto T, et al. Regulation of tubular recycling endosome biogenesis by the p53-MICALL1 pathway. Int j Oncol. 2017;51(2):724–736. doi:10.3892/ijo.2017.4060
   PubMed Web of Science ®Google Scholar
• Xiao Y, Najeeb RM, Ma D, et al. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms. J Exp Clin Cancer Res. 2019;38(1):458. doi:10.1186/s13046-019-1444-0
   PubMed Web of Science ®Google Scholar
• Wang Q, Yu X, Zheng Z, et al. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma. PeerJ. 2021;9:e11342. doi:10.7717/peerj.11342
   PubMed Web of Science ®Google Scholar
• Liu Y, Yao Y, Liao B, et al. A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma. Int J Biol Sci. 2022;18(10):4071–4087. doi:10.7150/ijbs.69495
   PubMed Web of Science ®Google Scholar
• Fridman WH, Pagès F, Sautès-Fridman C, et al. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306. doi:10.1038/nrc3245
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu H, Shen Z, et al. Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Ann Surg. 2018;267(2):311–318. doi:10.1097/SLA.0000000000002058
   PubMed Web of Science ®Google Scholar
• Lei X, Lei Y, Li JK, et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126–133. doi:10.1016/j.canlet.2019.11.009
   PubMed Web of Science ®Google Scholar
• Budhu A, Wang XW. The role of cytokines in hepatocellular carcinoma. J Leukoc Biol. 2006;80(6):1197–1213. doi:10.1189/jlb.0506297
   PubMed Web of Science ®Google Scholar
• Denardo DG, Barreto JB, Andreu P, et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 2009;16(2):91–102. doi:10.1016/j.ccr.2009.06.018
   PubMed Web of Science ®Google Scholar
• Montironi C, Castet F, Haber PK, et al. Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification. Gut. 2023;72(1):129–140. doi:10.1136/gutjnl-2021-325918
   PubMed Web of Science ®Google Scholar
• Fu Y, Mackowiak B, Feng D, et al. MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression. Gut. 2023;72(10):1942–1958. doi:10.1136/gutjnl-2022-327924
   PubMed Web of Science ®Google Scholar
• Wu C, Lin J, Weng Y, et al. Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma. J Clin Invest. 2020;130(9):4679–4693. doi:10.1172/JCI135048
   PubMed Web of Science ®Google Scholar